Stock Scorer

DataMeds AI, Inc. (MEDS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. Every figure as a table ›

Revenue Quarterly

0 5M 10M 15M Q2 '24: 44.5K Q3 '24: 5.7M Q4 '24: 12.4M Q1 '25: 10.9M Q2 '25: 7.8M Q3 '25: 3M Q4 '25: 1.7M Q1 '26: 1.6M Q2 '26: 1.8M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Gross Profit Quarterly

-9M -6M -3M 0 3M 6M 9M Q1 '24: 0 Q2 '24: -2.6K Q3 '24: 521.2K Q4 '24: 1.2M Q1 '25: 692.6K Q2 '25: 505.8K Q3 '25: 231K Q4 '25: -7.9M Q1 '26: 170.2K Q2 '26: 182.2K Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q1 '24: -79.8K Q2 '24: -573K Q3 '24: -1.7M Q4 '24: -3.7M Q1 '25: -31.3M Q2 '25: -5.5M Q3 '25: -31.5M Q4 '25: -25.4M Q1 '26: -6M Q2 '26: -7.3M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Net Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q1 '24: -83.1K Q2 '24: -574.3K Q3 '24: -1.9M Q4 '24: -4.3M Q1 '25: -32.4M Q2 '25: -6.7M Q3 '25: -34.3M Q4 '25: -27.9M Q1 '26: -7.7M Q2 '26: -18.4M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Cost of Revenue Quarterly

0 4M 8M 12M Q2 '24: 47.1K Q3 '24: 5.2M Q4 '24: 11.2M Q1 '25: 10.2M Q2 '25: 7.3M Q3 '25: 2.8M Q4 '25: 9.5M Q1 '26: 1.4M Q2 '26: 1.6M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Cash Flow Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q1 '24: 31.2K Q2 '24: 330K Q3 '24: 1M Q1 '25: -1.3M Q2 '25: -2.1M Q3 '25: -1.1M Q4 '25: -6.3M Q1 '26: -3.4M Q2 '26: -2.9M Q1 '24 Q3 '24 Q2 '25 Q4 '25 Q2 '26

Shares Outstanding Quarterly

0 40M 80M 120M Q1 '24: 44.7M Q2 '24: 45.9M Q3 '24: 48.4M Q1 '25: 51.9M Q2 '25: 1.2M Q3 '25: 74.4M Q1 '26: 104.6M Q2 '26: 2.6M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-7.50 -5.00 -2.50 0.00 2.50 5.00 7.50 Q4 '24: -0.15 Q1 '25: -0.77 Q2 '25: -6.16 Q3 '25: -6.58 Q4 '24 Q1 '25 Q2 '25 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

Not drawn for MEDS: Free Cash Flow. Nothing in this filer's XBRL supports it for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.